{"id":"https://openalex.org/W185032011","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.5551","title":"A phase II trial of docetaxel and cisplatin combination in patients with locally advanced undifferentiated carcinoma of the nasopharynx: updated results","display_name":"A phase II trial of docetaxel and cisplatin combination in patients with locally advanced undifferentiated carcinoma of the nasopharynx: updated results","publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W185032011","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.5551","mag":"185032011"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2005.23.16_suppl.5551","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.5551","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.5551","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037285054","display_name":"M. Yamouni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163666","display_name":"University Hospital of Oran","ror":"https://ror.org/023d4z626","country_code":"DZ","type":"healthcare","lineage":["https://openalex.org/I4210163666"]}],"countries":["DZ"],"is_corresponding":false,"raw_author_name":"M. Yamouni","raw_affiliation_strings":["CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria","institution_ids":["https://openalex.org/I4210163666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006585898","display_name":"Karim Adnane Benhadji","orcid":"https://orcid.org/0000-0001-9883-6970","observed_orcids":["https://orcid.org/0000-0001-9883-6970"]},"institutions":[{"id":"https://openalex.org/I4210163666","display_name":"University Hospital of Oran","ror":"https://ror.org/023d4z626","country_code":"DZ","type":"healthcare","lineage":["https://openalex.org/I4210163666"]}],"countries":["DZ"],"is_corresponding":false,"raw_author_name":"K. A. Benhadji","raw_affiliation_strings":["CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria","institution_ids":["https://openalex.org/I4210163666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050881855","display_name":"Y. Beldjilali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163666","display_name":"University Hospital of Oran","ror":"https://ror.org/023d4z626","country_code":"DZ","type":"healthcare","lineage":["https://openalex.org/I4210163666"]}],"countries":["DZ"],"is_corresponding":false,"raw_author_name":"Y. Beldjilali","raw_affiliation_strings":["CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria","institution_ids":["https://openalex.org/I4210163666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054385601","display_name":"I. Lahfa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163666","display_name":"University Hospital of Oran","ror":"https://ror.org/023d4z626","country_code":"DZ","type":"healthcare","lineage":["https://openalex.org/I4210163666"]}],"countries":["DZ"],"is_corresponding":false,"raw_author_name":"I. Lahfa","raw_affiliation_strings":["CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria","institution_ids":["https://openalex.org/I4210163666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057081725","display_name":"Djamila Yekrou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163666","display_name":"University Hospital of Oran","ror":"https://ror.org/023d4z626","country_code":"DZ","type":"healthcare","lineage":["https://openalex.org/I4210163666"]}],"countries":["DZ"],"is_corresponding":false,"raw_author_name":"D. Yekrou","raw_affiliation_strings":["CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria","institution_ids":["https://openalex.org/I4210163666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074092300","display_name":"L. Djellali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163666","display_name":"University Hospital of Oran","ror":"https://ror.org/023d4z626","country_code":"DZ","type":"healthcare","lineage":["https://openalex.org/I4210163666"]}],"countries":["DZ"],"is_corresponding":false,"raw_author_name":"L. Djellali","raw_affiliation_strings":["CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria","institution_ids":["https://openalex.org/I4210163666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065744880","display_name":"Mourad Brahimi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163666","display_name":"University Hospital of Oran","ror":"https://ror.org/023d4z626","country_code":"DZ","type":"healthcare","lineage":["https://openalex.org/I4210163666"]}],"countries":["DZ"],"is_corresponding":false,"raw_author_name":"M. Brahimi","raw_affiliation_strings":["CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria","institution_ids":["https://openalex.org/I4210163666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072691573","display_name":"M. A\u00eft-Said","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163666","display_name":"University Hospital of Oran","ror":"https://ror.org/023d4z626","country_code":"DZ","type":"healthcare","lineage":["https://openalex.org/I4210163666"]}],"countries":["DZ"],"is_corresponding":false,"raw_author_name":"M. A\u00eft-Said","raw_affiliation_strings":["CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria","institution_ids":["https://openalex.org/I4210163666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063576946","display_name":"Kheira Bouzid","orcid":"https://orcid.org/0000-0001-8233-3308","observed_orcids":["https://orcid.org/0000-0001-8233-3308","https://orcid.org/0000-0003-4178-8773"]},"institutions":[{"id":"https://openalex.org/I4210163666","display_name":"University Hospital of Oran","ror":"https://ror.org/023d4z626","country_code":"DZ","type":"healthcare","lineage":["https://openalex.org/I4210163666"]}],"countries":["DZ"],"is_corresponding":false,"raw_author_name":"K. Bouzid","raw_affiliation_strings":["CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Oran - Dept of Medcl Oncology, Oran, Algeria; Aventis Pharma, Algiers, Algeria; Sanofi-Aventis Pharma, Algiers, Algeria; Ctr Pierre &amp; Marie Curie, Algiers, Algeria","institution_ids":["https://openalex.org/I4210163666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210163666"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"16_suppl","first_page":"5551","last_page":"5551"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11669","display_name":"Head and Neck Surgical Oncology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nasopharyngeal-carcinoma","display_name":"nasopharyngeal carcinoma","score":0.800000011920929},{"id":"https://openalex.org/keywords/undifferentiated-carcinoma","display_name":"undifferentiated carcinoma","score":0.9110000133514404},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9610000252723694},{"id":"https://openalex.org/keywords/locally-advanced-disease","display_name":"locally advanced disease","score":0.8270000219345093},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.6039999723434448},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7419999837875366},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.7239999771118164},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6990000009536743},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.5870000123977661},{"id":"https://openalex.org/keywords/locoregional-recurrence","display_name":"locoregional recurrence","score":0.8899999856948853},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.6639999747276306},{"id":"https://openalex.org/keywords/locoregional-radiotherapy","display_name":"locoregional radiotherapy","score":0.7179999947547913},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.492000013589859},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6480000019073486},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.3799999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9464957118034363},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.724018931388855},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.7069295644760132},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6917312741279602},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6052796840667725},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5361279249191284},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5299010872840881},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.520774781703949},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.4745531678199768},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4687238931655884},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4684735834598541},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4627428650856018},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.46244269609451294},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34538161754608154}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2005.23.16_suppl.5551","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.5551","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.5551","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2246080234","https://openalex.org/W4229482839","https://openalex.org/W2599291417","https://openalex.org/W2589410320","https://openalex.org/W2222761521","https://openalex.org/W2548598002","https://openalex.org/W2921138031","https://openalex.org/W2223769017","https://openalex.org/W2589719148","https://openalex.org/W2736370837"],"abstract_inverted_index":{"5551":[0],"Background:":[1],"The":[2,22,250],"standard":[3],"treatment":[4],"of":[5,10,24,35,103,113,156,168,304],"locally":[6,57,342],"advanced":[7,58,343],"undifferentiated":[8],"carcinoma":[9],"nasopharyngeal":[11],"type":[12],"(UCNT)":[13],"is":[14,27,332],"cisplatin":[15,45],"based":[16],"chemotherapy":[17,39],"followed":[18],"by":[19,108],"locoregional":[20],"radiotherapy.":[21],"purpose":[23],"this":[25],"study":[26],"to":[28,96,314],"assess":[29],"the":[30,100,225],"antitumor":[31],"activity":[32],"and":[33,44,48,62,70,115,125,134,163,184,208,245,264,276,286,291,300,320,325],"toxicity":[34,197],"a":[36,90,153,164],"new":[37],"neoadjuvant":[38,91],"regimen":[40,335],"combining":[41],"docetaxel":[42],"(D)":[43],"(C).":[46],"Patients":[47],"Methods:":[49],"Previously":[50],"untreated":[51],"patients":[52,271],"(pts)":[53],"with":[54,117,152,280,336],"histologically":[55],"diagnosed":[56],"UCNT":[59],"(Stages":[60],"IVA":[61,183,319],"IVB":[63,321],"TNM/UICC":[64],"1997)":[65],"received":[66,86],"D":[67],"75":[68,72,146,226],"mg/m2":[69,73],"C":[71],"both":[74],"on":[75],"day":[76],"1,":[77],"cycles":[78,88],"were":[79,106,122,139,297],"repeated":[80],"every":[81],"21":[82,150],"days.":[83],"Every":[84],"pts":[85,147,180,186,219,227,258],"three":[87],"in":[89,141,172,176,341],"setting":[92],"before":[93],"radiotherapy":[94,263],"(4":[95],"6":[97],"weeks":[98],"after":[99,262],"third":[101],"cycle":[102],"DC).":[104],"Pts":[105],"evaluated":[107],"clinical":[109],"examination,":[110],"CT":[111],"scan":[112],"nasopharynx":[114],"nasofibroscopy":[116],"biopsy.":[118],"Primary":[119],"end":[120],"points":[121],"tumor":[123,132,309],"response":[124,133,231,236,252,261],"disease":[126,241],"free":[127],"survival":[128,135,293],"(DFS)":[129],"Results:":[130],"Toxicity,":[131],"over":[136],"one":[137,265],"year":[138,296],"assessable":[140],"all":[142],"pts.":[143,178],"There":[144],"are":[145],"(54":[148],"male,":[149],"female)":[151],"median":[154],"age":[155],"41":[157],"years":[158],"(range":[159],"18":[160],"-":[161,170],"69)":[162],"WHO":[165],"performance":[166],"status":[167],"0":[169],"1":[171,283,287,295],"71":[173],"pts,":[174],"2":[175],"4":[177,196,277],"19":[179,274],"had":[181,187,220,259,267,272],"stage":[182,188,310,318],"56":[185],"IVB.":[189],"After":[190],"225":[191],"cycles,":[192],"grade":[193],"3":[194],"&":[195],"(WHO)":[198],"were:":[199,228],"neutropenia":[200,203],"(12%),":[201],"febrile":[202],"(2%),":[204],"anemia":[205],"(1%),":[206,214],"nausea":[207],"vomiting":[209],"(23%),":[210],"diarrhea":[211],"(8%),":[212],"mucositis":[213],"reversible":[215],"alopecia":[216],"(70%).":[217],"Two":[218],"onycolysis.":[221],"Response":[222],"rates":[223],"for":[224],"complete":[229,260],"pathologic":[230],"37%":[232],"(28":[233],"pts),":[234,239],"partial":[235],"52%":[237],"(39":[238],"stable":[240,268],"8%":[242],"(6":[243],"pts)":[244],"progression":[246],"3%":[247],"(2":[248,279],"pts).":[249],"overall":[251,292],"rate":[253],"(ORR)":[254],"was":[255,311,323],"90%.":[256],"72":[257],"patient":[266],"disease.":[269],"23":[270],"recurrence:":[273],"locoregional,":[275],"metastatic":[278],"bone":[281],"metastasis,":[282],"hepatic":[284],"metastasis":[285],"cerebral":[288],"metastasis).":[289],"DFS":[290,322],"at":[294],"respectively":[298,328],"69%":[299],"72%.":[301],"Multivariate":[302],"analysis":[303],"prognostic":[305],"factors":[306],"revealed":[307],"that":[308],"independently":[312],"related":[313],"poor":[315],"DFS.":[316],"For":[317],"13.89":[324],"17.22":[326],"months":[327],"(p=0.02).":[329],"Conclusion:":[330],"DC":[331],"an":[333,337],"effective":[334],"acceptable":[338],"safety":[339],"profile":[340],"UCNT.":[344],"Author":[345],"Disclosure":[346],"Employment":[347],"or":[348,351],"Leadership":[349],"Consultant":[350],"Advisory":[352],"Role":[353],"Stock":[354],"Ownership":[355],"Honoraria":[356],"Research":[357],"Funding":[358],"Expert":[359],"Testimony":[360],"Other":[361],"Remuneration":[362],"Aventis,":[363],"sanofi-aventis":[364]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2016-06-24T00:00:00"}
